n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, January 3rd, 2018

The QualityStocks
Daily Stock List

graphic
graphic

ProtoKinetix, Inc. (PKTX)

SmallCapVoice, TopPennyStockMovers, 777 Stocks, Breaking Bulls, InsideBulls, Stock Market News Alert, HotOTC, OTCReporter, Stock Rich, PennyStockAce, Stockpalooza, SuperBirdStocks, WallStAlerts, Willy Wizard, Pick Alerts, Penny stock Profitz, AllPennyStocks, Penny Invest, CoolPennyStocks, StockEgg, and Round Up the Bulls reported earlier on ProtoKinetix, Inc. (PKTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, ProtoKinetix, Inc. is a molecular biotechnology company. It has developed and patented a family of hyper stable, potent glycopeptides (Anti-Aging GlycoPeptide - AAGP™), which enhance engraftment and protection of transplanted cells used in regenerative medicine. Because of the anti-inflammatory effect of AAGP™ molecules, ProtoKinetix is now targeting the direct treatment of diseases that have a major inflammatory component. The Company’s molecule, AAGP™, is an antifreeze glycopeptide. It imitates a naturally occurring glycoprotein found in Arctic fish. ProtoKinetix is based in Marietta, Ohio.

The Company’s AAGP™ molecule is helping to considerably improve the efficacy of Cell Transplant Treatments for diabetes. ProtoKinetix has extensive patent protection for its portfolio of anti-aging glycopeptides. The Company’s anti-aging glycopeptide, trademarked AAGP™, is a small (580.96 Daltons), stable, synthetic replica of the larger (>2,600 Daltons), less stable AFGP that has been found to have protective properties in nature.

The small size of AAGP™ enables it to penetrate cells and allows it to pass through cell and capillary junctions in vivo. Also, its bioactivity at a range of pHs (5.3-10.3) and temperatures (-196°C to 22°C) and efficiency at concentrations (1mg/ml) is well under its toxic dose (50mg/ml). This makes it a candidate to enter the next stages of translational research.

In March 2017, ProtoKinetix announced the start of a Phase 1 first-in-human clinical trial of AAGP™ PKX-001 treated islet cells used together with the Edmonton Protocol for the treatment of Type 1 diabetes. The first patient was treated under the protocol.

In May 2017, ProtoKinetix announced that it completed the first year of retinal replacement therapy trials on animals. It said that the results are encouraging enough to proceed to a second phase of testing. The cells treated with AAGP™ showed an improvement on cell survivability and viability in comparison to the untreated cells. Continuing testing is now taking place to determine if these transplanted cells are fully functioning.

ProtoKinetix and Proactive Immune Sciences entered into a joint research collaboration. The goal of the research is to test the effect of the patented anti-aging glycopeptide AAGP™ on the immune cell cryopreservation protocols used by Proactive Immune Sciences.

Recently, ProtoKinetix, provided a scientific update on immune cell banking and functions relevant to immunotherapy utilizing AAGP™ in collaboration with Proactive Immune Sciences. Earlier in 2017, Proactive started a research program that used an anti-aging glycopeptide (AAGP™) produced by ProtoKinetix that, among other uses, has shown the potential to benefit various cells during cryopreservation.

In the research program, Proactive Immune Sciences is investigating whether the AAGP™ produced by ProtoKinetix improves survival and function of cryopreserved immune cells through assessment of the effect of AAGP™ on cryopreserved immune cell viability and functionality. Proactive Immune Sciences stores (banks) immune cells, while people are healthy. This is for them to use later in life should they contract cancer or have other immune system related diseases.

ProtoKinetix, Inc. (PKTX), closed Wednesday's trading session at $0.063, up 6.78%, on 109,597 volume with 8 trades. The average volume for the last 60 days is 92,881 and the stock's 52-week low/high is $0.0401/$0.189.

Medicine Man Technologies, Inc. (MDCL)

CFN Media Group, The Street, MarketWatch, Marketwired, and Stockhouse reported on Medicine Man Technologies, Inc. (MDCL), and we report on the Company as well, here at the QualityStocks Daily Newsletter

Medicine Man Technologies, Inc. represents and licenses the cultivation and dispensary Intellectual Property (IP) of Medicine Man - a well-respected Tier III operator in Colorado. Medicine Man Technologies provides cultivation consulting services for cannabis growing technologies and methodologies. The Company is one of the nation’s foremost cannabis brand development and consulting enterprises. Established in 2014, Medicine Man is based in Denver, Colorado. The Company lists on the OTCQB.

Medicine Man works closely with industry-leading extraction partners. These partners provide the required licensing service support and formulations to help customers with their planned deployment of a successful processing facility.

At present, Medicine Man Technologies has 63 active clients in California, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, Massachusetts, Puerto Rico, Australia, Canada, Germany, and South Africa.

The Company is concentrating on working with clients to use its experience, technology, and training to help secure a license in states with newly emerging regulations. In addition, it is centering on deploying its highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminating the liability of single grower dependence.

Medicine Man is also continuing the expansion of its Brands Warehouse concept. Also, the Company engages in retail operations of cannabis products. It additionally provides general business and referral management for other related service providers for its customers. It cultivates and sells through its parent company Medicine Man Denver, the largest cultivation/retail facility in the State of Colorado.

Medicine Man’s risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. The Company’s state-of-the art dispensary model ensures patients and consumers have safe and secure access to a variety of medical and/or recreational cannabis products.

Earlier, Medicine Man Technologies announced that the definitive agreement to acquire Denver Consulting Group, LLC was executed by the parties on July 21, 2017. The acquisition became effective on July 24th upon the filing of applicable documents with the Colorado Secretary of State. Denver Consulting Group has offices in Denver, Colorado, and Portland, Oregon.

Medicine Man Technologies has recently added two new clients. The Company now has cultivation projects representing just over 700,000 gross square feet of California based project space. These projects represent numerous clients, some of which are considering stacking of the 10,000-square foot license type (small indoor) as presently expected to be allowable under the initial draft regulations recently released.

Medicine Man Technologies, Inc. (MDCL), closed Wednesday's trading session at $3.18, up 11.97%, on 228,665 volume with 469 trades. The average volume for the last 60 days is 39,906 and the stock's 52-week low/high is $0.92/$3.02.

Alliance BioEnergy Plus, Inc. (ALLM)

Stocks That Move reported earlier on Alliance BioEnergy Plus, Inc. (ALLM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Alliance BioEnergy Plus, Inc. focuses on the commercialization and licensing of a patented cellulose conversion technology. It controls this technology through a master license agreement with the University of Central Florida. Alliance BioEnergy Plus’s subsidiaries focus on developing technologies in the renewable energy, bio-fuels, as well as new technologies sectors. OTCQB-listed, Alliance BioEnergy Plus is headquartered in West Palm Beach, Florida.

The Company operates various subsidiaries. AMG Energy Group, LLC owns 50 percent of Carbolosic, LLC (in a joint venture (JV) with Thor Renewable Energy Singapore) and exclusively the territories of North America and Africa. Carbolosic holds the exclusive worldwide license for the patented CTS™ (Cellulose to Sugar) process, developed and owned by the University of Central Florida.

Carbolosic holds the exclusive, worldwide license to four issued patents and 14 filed and pending patents revolving around the core CTS (cellulose to sugar) technology.

The CTS™ process converts cellulose into commercial grade sugars, fine chemicals, and other highly valuable products. Alliance BioEnergy Plus’s intention is to center on the production of these commercial products by way of company-owned and licensed facilities

The Company’s commercial pilot/demonstration and research facility, Ek Laboratories, LLC, came online in early 2015. Under the direction of CTS™ inventor Dr. Richard Blair, the facility is running the CTS process, at a commercial scale, and is providing licensees with real time analytics.

The AMG Energy Group subsidiary was created to be the technology arm of the Company. AMG concentrates on the licensing of Alliance BioEnergy Plus’s Intellectual Property (IP), engineering and construction of CTS plants, and developing technologies in the renewable energy, bio-fuels, and new technology sectors.

The CTS Cellulose Ethanol technology can produce a high quality, clean burning Ethanol from almost any plant material less costly, faster, and without any hazardous inputs. The Company has completed the construction of its commercial scale CTS demonstration plant and research laboratories at its subsidiary Central Florida Institute of Science and Technology, Inc. (CFIST).

Alliance BioEnergy Plus earlier filed an 8K with the SEC (Securities and Exchange Commission) disclosing that its subsidiary, Alliance Bio-Products, Inc., entered into a material definitive agreement to purchase the closed ethanol facility in Indian River County, Florida.

The Company received approval from the United States Department of Agriculture (USDA) Office of Rural Development (USDA Rural Development) to move ahead with the purchase in early July 2017. The approved purchase, at a price of $8M, includes the fully functional plant, 144-plus acres that the plant resides on, and all related equipment and vehicles.

Recently, Alliance BioEnergy Plus announced that wholly-owned subsidiary, Ek Laboratories, received a six-figure payment from Phoenix Biomaterials Thomaston, LLC, upon their completion of due diligence of the CTS process, for successful feedstock evaluation and also preliminary engineering reports, related to building a Greenfield (new plant from the ground up) CTS plant. Phoenix’s intention is to enter into a sublicense agreement with the Company once they finalize the logistics of their initial site based on the reports purchased from Alliance BioEnergy Plus.

Alliance BioEnergy Plus, Inc. (ALLM), closed Wednesday's trading session at $0.0299, up 39.07%, on 1,507,842 volume with 79 trades. The average volume for the last 60 days is 595,403 and the stock's 52-week low/high is $0.02/$0.40.

Ecosphere Technologies, Inc. (ESPH)

Buzz Stocks, Penny Pick Finders, PennyStockProphet, SmallCapVoice, Wall Street Resources, TheMicrocapNews, PennyStocks24, Planet Penny Stocks, SecretStockPromo, and StockOnion reported previously on Ecosphere Technologies, Inc. (ESPH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Ecosphere Technologies, Inc. is a development and Intellectual Property (IP) licensing company. It develops environmental solutions for worldwide water, energy, industrial, and agricultural markets. The Company helps industry boost production, reduce costs, and protect the environment through a portfolio of unique, patented technologies and exclusive and nonexclusive licensing opportunities across a broad array of industries and applications globally. Ecosphere Technologies is headquartered in Stuart, Florida.

Ecosphere has an extensive portfolio of patented clean technologies. These can be purchased and licensed for use in large-scale and sustainable applications across industries, nations, as well as ecosystems. The Company’s technologies include the Ecos PowerCube®, the Ecos GrowCube™, and Ozonix®.

The Ecosphere technologies and products are available by way of numerous brands and subsidiaries. These include Sea of Green Systems, Ecosphere Development Company, and Fidelity National Environmental Solutions. Ecosphere’s objective is to help clean energy producers’ gain more control over their water resources, quality, and completion costs through providing effective mobile water recycling solutions.

The Ecosphere Ozonix® Technology provides a chemical-free alternative to high-volume water recycling for a diverse range of applications. These range from the oil & natural gas industry and mining to agriculture and municipal wastewater treatment.

The Ecos GrowCube® is a state-of-the-art, turn-key, fully-automated "greenhouse". It employs hydroponic growing techniques to maximize the amount of crop production possible in a given footprint. The Ecos GrowCube® incorporates the Company’s patented Ozonix® water treatment technology.

The Ecos PowerCube® is the world’s largest, mobile, solar-powered generator. It runs on high power photovoltaic panels. These panels extend from its container combined with an easy to set up wind turbine. Energy is stored in onboard batteries.

Furthermore, Ecosphere has its Ozonix Sentinel. This is the world's first line of water treatment vessels for cleaning up endangered rivers and lakes.

Sea of Green Systems’ (SOGS) sublicensee in the agricultural industry, Gulf Coast Organics (GCO), signed an agreement with Wedgworth's, Inc., to be the exclusive distributor in Florida for its Amp Agronomy™ plant nutritional line. Wedgworth's provides custom blended agricultural plant nutrient products across Florida to help farms grow and prosper. CAVISONIX®, developed by SOGS and Ecosphere Technologies, uses ultrasonic cavitation to treat fertilizers for increased plant availability.

Wedgworth's is recognized as Florida's largest custom fertilizer dealer since 1932. Sea of Green Systems, Inc. (SOGS) is a subsidiary of Ecosphere Technologies. SOGS develops proprietary equipment, lighting and fertilizer solutions for the Precision Agriculture industry.

Ecosphere Technologies, Inc. (ESPH), closed Wednesday's trading session at $0.0142, up 19.33%, on 341,156 volume with 19 trades. The average volume for the last 60 days is 237,216 and the stock's 52-week low/high is $0.0101/$0.0738.

Asia Equity Exchange Group, Inc. (AEEX)

OTC Markets, InvestorsHub, and MarketWatch reported on Asia Equity Exchange Group, Inc. (AEEX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Asia Equity Exchange Group, Inc. is working to establish and build an equity information service platform designed to provide equity investment financing information to all enterprises in the nations and regions of Asia. Asia Equity Exchange Group, with its website www.asiaotcmarkets.com, invested and operated by Asian Equity Exchange Group Co., Ltd., is an intercontinental equity exchange and a service platform for companies in Asia to release equity investment and financing information.

Asia Equity Exchange Group has offices in Kowloon Bay, Hong Kong; Shenzhen, China; and New York, New York. The Company lists on the OTC Markets Group’s OTCQB.

The operating structure of the Company is: Asia Equity Exchange Group, Inc. 100 percent shareholding Asian Equity Exchange Group Co. Ltd. 100 percent shareholding AEEX (HK) International Financial Services Limited 100 percent shareholding Asian & American Consultant (Shenzhen) Co. Ltd.

In essence, Asia Equity Exchange Group integrates worldwide capital and works with providers of a broad array of services. The Company provides growing and innovative companies with diversified and professional services, and global professional investors with quality, open, and diverse investment opportunities. It serves as a significant part and a vital link of the multi-layered capital markets in Asia. Asia Equity Exchange Group enables companies to obtain the resources to successfully launch their IPO (Initial Public Offering).

Asia Equity Exchange Group helps companies develop in a sustainable manner. Furthermore, the Company introduces high-value investment markets to professional institutional and individual investors.

In addition, it aims to create a unique and authoritative intercontinental equity information platform, which effectively complements business functions, service means and financing channels with OTC markets in different nations and regions.

Asia Equity Exchange Group is also working to build a system of intercontinental cooperation to provide listed enterprises with equity financing means through domestic and out of the country channels, and to provide nurturing, pre-listing tutoring, and incubating, and also supporting services for their listing on overseas capital markets by shifting boards.

Asia Equity Exchange Group introduces global securities and institutional investors in its shareholder structure. Moreover, it partners with international organizations in its operations. These include investment banks, financial and legal institutions, and professional consulting teams.

In December, Asia Equity Exchange Group hosted a media event at the Hilton Shenzhen Futian, announcing the successful financing of $15 million USD for a private placement deal. The AEEX management team and guest speakers examined the development of the private placement process and discussed how Chinese SMEs (small and medium sized enterprises) can develop faster and more effective methods to operate in capital markets.

Asia Equity Exchange Group, Inc. (AEEX), closed Wednesday's trading session at $5.20, down 2.44%, on 30,300 volume with 8 trades. The average volume for the last 60 days is 3,092 and the stock's 52-week low/high is $4.99/$21.11.

Margaux Resources Ltd. (MARFF)

Equities, 4-Traders, MarketWatch, Stockhouse, and OTC Markets reported on Margaux Resources Ltd. (MARFF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Margaux Resources Ltd. is a mineral acquisition and exploration company headquartered in Calgary, Alberta. The Company’s emphasis is on zinc, gold and tungsten resources in the richly mineralized Kootenay Arc region of southeastern British Columbia. These include the Jersey-Emerald, Sheep Creek, and Bayonne, Jackpot, Canex, Ore Hill and AspenEx properties. Margaux Resources’ shares trade on the OTC Markets’ OTCQB.

On the basis of historic production, Margaux Resources’ Jersey-Emerald property is the third largest zinc-lead producer in British Columbia, and also the second largest tungsten producer in North America. The Company’s close by Sheep Creek property has historic gold production totaling 690,000 ounces, from 26 historic gold vein mines. It is analogous to the Barkerville District of central British Columbia.

The Jersey-Emerald property is a zinc-lead, tungsten + gold project, acquired in 2014. The Jackpot property is a zinc, lead + silver property, acquired in 2016. The Bayonne & Sheep Creek gold + silver properties were acquired in January 2017. The Ore Hill & AspenEx gold, silver + zinc-lead properties were acquired in March 2017.

Margaux Resources has a large land position: 22,353 ha (55,235 acres) of claims. The Company has extensive historic data on all properties. In addition, it has near-term cash flow potential from historic tailings.

The above-mentioned Kootenay Arc region is a massive past producer of gold, zinc & tungsten. There has been little lead-zinc mining activity since the 1970/80s and gold activity since the 1940s. It is here that Margaux Resources has amassed 22,353 hectares of high quality mineral, crown & placer claims. The Company’s assets lie within the Kootenay Arc. The zinc-lead-silver belt extends 300 kilometers.

In 2017, Margaux Resources conducted its exploration program, including Diamond Drilling: Sheep Creek & Bayonne (Gold) and Jackpot (Zinc). The Company has its Sheep Creek NI 43-101 Report.

The Company’s assets are located in a prolific and mining friendly district near the historic town of Salmo, where Margaux has established a fully operational office. Margaux Resources has a pipeline of projects with Greenfield and Brownfield potential with premier infrastructure situated 45 kilometers from a zinc-lead smelter.

Recently, Margaux Resources announced that it acquired additional claims to expand its Kootenay Arc project holdings in southeastern British Columbia. Furthermore, Margaux received high-grade gold grab sample results from the Sheep Creek and Bayonne properties.

Highlights include 1,670 hectares of newly acquired mineral claims; orogenic gold mineralization favorable area; a high-grade gold sample at Sheep Creek including up to 15.5 g/t Au; a 13.0 g/t Au grab sample returned from Bayonne; as well as a new vein discovered at Bayonne.

Margaux Resources Ltd. (MARFF), closed Wednesday's trading session at $0.227, even for the day. The average volume for the last 60 days is 1,420 and the stock's 52-week low/high is $0.1581/$0.267.

True Leaf Medicine International Ltd. (TRLFF)

Investing, Stockhouse, and MarketWatch reported on True Leaf Medicine International Ltd. (TRLFF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

True Leaf Medicine International Ltd., by way of its wholly-owned subsidiary 'True Leaf Pet, Inc.', has entered the global pet industry with a line of hemp-focused pet supplements in the United States, Canada, and Europe. The Company’s other subsidiary is ‘True Leaf Medicine, Inc.’. True Leaf Medicine International is based in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

True Leaf Pet established in 2015 to pioneer and market hemp-focused products for the pet industry. The Company’s Pet segment markets only legal hemp-seed based pet products online, and also in stores throughout the United States, Canada, Europe, and New Zealand.

True Leaf Medicine came on the scene in 2013 to become a licensed producer of medical cannabis. It has received approval from the Government of Canada to build its facilities. At present, the Company does not have a license to produce cannabis.

The Company has filed an application under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer of medical cannabis through 'True Leaf Medicine'. True Leaf has passed through the preliminary and enhanced screening process of Health Canada's review.

True Leaf anticipates that the first phase of the build will include yearly production of 2,500 kilograms of dried cannabis once the facility passes Health Canada's inspection and True Leaf becomes a licensed producer.

Yesterday, True Leaf Medicine International announced that it exercised its option to purchase 40 acres of land, which encompasses its facility in Lumby, British Columbia, via its wholly owned subsidiary True Leaf Medicine, Inc.
The option was exercised on December 22, 2017 at a total cost of $3.3 million CAD. An up-front fee of $100,000 CAD was paid to the vendor for securing the option. True Leaf now has 30 days from that date to finalize the purchase.

True Leaf expects site and foundation work to commence in the coming weeks to be completed by summer 2018. The Company’s application to produce and distribute cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) has completed the security clearance stage.

True Leaf Medicine International Ltd. (TRLFF), closed Wednesday's trading session at $1.23, up 21.58%, on 176,660 volume with 226 trades. The average volume for the last 60 days is 43,865 and the stock's 52-week low/high is $0.16/$1.10.

graphic

The QualityStocks
Company Corner

graphic
graphic

Tapinator, Inc. (TAPM)

The QualityStocks Daily Newsletter would like to spotlight Tapinator, Inc. (TAPM). Today, Tapinator, Inc. closed trading at $0.2786, up 61.04%, on 1,487,265 volume with 460 trades. The stock’s average daily volume over the past 60 days is 105,792 and its 52-week low/high is $0.0711/$0.2419.

Tapinator, Inc. (OTCQB: TAPM), today announces the formation of a new subsidiary, Revolution Blockchain, LLC, to develop and publish distributed apps and games that leverage blockchain technology.

Tapinator, Inc. (TAPM) is a developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The Company's portfolio includes over 300 mobile gaming titles generating hundreds of thousands of daily player downloads that provide predictable and attractive returns through the sale of branded advertisements and consumer app store transactions. Tapinator, based in New York and with product development teams located throughout the world, was founded in 2013 by a visionary team that has been building mobile games and applications since 2007 and has achieved multiple successful exits.

Tapinator's business strategy includes the creation of a select number of best-in-class Full-Featured Games, such as ROCKY™ and Solitaire Dash, which provide game players with more in-depth, unique content that supports long-term retention and generates higher investment returns. The Full-Featured Games model creates the potential for sustainable $100+ million franchise-type games that have product lifespans of at least five years. Tapinator uses a proprietary set of dynamic development and marketing processes factored upon gaming category, estimated player retention and projected player profitability.

Recent successful launches of two new Full-Featured titles – Big Sport Fishing 2017 and Dice Mage 2 – were recognized on the Apple iOS platform as "New Games We Love." During the game's first seven days after global release, Big Sport Fishing 2017 received well over 520,000 player downloads. Four new titles, ColorFill, Divide & Conquer, Shadowborne and Fusion Heroes, are in the pipeline for release in Q4 2017 and Q1 2018 as well. The formula for these game combines proven gameplay elements with best-in-class monetization systems, supplemented by Tapinator's strong creative team of developers, strategists and product specialists. The company's Rapid-Launch Games division also saw increasing player interest recently with the launch of Fidget Spinner Superhero and Scary Shark Evolution 3D.

Tapinator's diversified revenue sources includes 54 percent from advertising placed within its mobile games and 46 percent from consumer app store purchases. The Company limits advertising placements to between game levels and also runs rewarded video ad units that are tied directly into the game's currency. Tapinator's portfolio includes more than 300 active titles, with no single game accounting for more than 25 percent of total revenues during the first half of 2017.

As Tapinator looks toward the future, opportunities in Virtual Reality (VR) and Augmented Reality (AR) show great promise. The company has released several prototype VR games to gather data before pursuing a more significant VR product. Recent market reports suggest that the VR industry will hit $30 billion by 2020 and the AR industry will surpass that with a projected $120 billion. Tapinator also plans to pursue publishing transactions that leverage its network, platform relationships and operational excellence. Significant opportunities for expanding Tapinator's gaming IP to new platforms such as Steam and leading messaging apps are also on the horizon. The company is targeting a 30+ percent annual bookings growth target for 2017-2019. Disclaimer

Tapinator, Inc. Blog

Tapinator, Inc. News:

Tapinator Introduces New Subsidiary Focused on Decentralized Blockchain Apps

NetworkNewsWire Announces Publication on M&A in the Mobile Gaming Industry

Mobile Gaming Acquisitions on Pace to Boom in 2018

First Cobalt Corp. (TSX.V:FCC) (OTCQB:FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $1.2007, up 14.35%, on 2,541,533 volume with 2,352 trades. The stock’s average daily volume over the past 60 days is 135,988, and its 52-week low/high is $0.3148/$1.3041.

First Cobalt Corp. (TSX-V: FCC, ASX: FCC, OTCQB: FTSSF) (the "Company") is pleased to announce its management team will be attending three upcoming conferences. First Cobalt will be speaking at the TD Mining Conference in Toronto and the Vancouver Resource Investment Conference (VRIC). The Company will be hosting booths at both the VRIC, followed by the AME RoundUp in Vancouver.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

First Cobalt to Present at TD Mining Conference and the Vancouver Resource Investment Conference

First Cobalt Closes $30.6 Million Financing

First Cobalt Announces $25 Million Bought Deal Private Placement Financing

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.877, up 3.18%, on 258,281 volume with 167 trades. The stock’s average daily volume over the past 60 days is 223,045 and its 52-week low/high is $0.40/$2.75.

NetworkNewsAudio, via NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the online availability of its interview with ChineseInvestors.com (OTCQB:CIIX), a leading financial information website for Chinese-speaking investors in the United States and China that is also laying the groundwork to capitalize on unprecedented opportunities in the cryptocurrency and cannabis sectors. The interview can be heard at http://nnw.fm/ciix-interview-jan-2018

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

NetworkNewsWire Releases Exclusive Audio Interview with ChineseInvestors.com (CIIX)

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Provides Post-Holiday Update on Baijiu Sales

NetworkNewsAudio Covers ChineseInvestors.com’s Release on Recent Interview on Top-Rated Cryptocurrency Podcast

EVIO, Inc. (EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO). Today, EVIO, Inc. closed trading at $2.15, up 0.47%, on 565,506 volume with 989 trades. The stock’s average daily volume over the past 60 days is 67,990, and its 52-week low/high is $0.47/$3.20.

EVIO, Inc. (EVIO), is pleased to announce the appointment of Al Lustig as President of EVIO, Inc., reporting to William Waldrop, EVIO Chief Executive Officer. Lustig’s primary responsibility will be to drive EVIO’s growth in both new and existing markets by developing and executing national and international sales and operational strategies.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry. Disclaimer

EVIO, Inc. Company Blog

EVIO, Inc. News:

EVIO Inc. Announces the Appointment of New President, Albert Lustig

EVIO Inc. Completes Acquisition of Licensed California Cannabis Testing Laboratory

EVIO Labs Colorado Licensee Announces ISO 17025 Accreditation

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0695, up 0.72%, on 7,265,239 volume with 636 trades. The stock’s average daily volume over the past 60 days is 11,461,156, and its 52-week low/high is $0.009/$0.16.

Global Payout, Inc. (OTCPink:GOHE) ("Global") is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. ("MTRAC" "MoneyTrac", the "Company") has promoted Ms. Vanessa Luna to the distinguished role and position of Chief Executive Officer. Former CEO, James Hancock will assume the distinguished role of the Company's Chairman of the Board. Both appointments are effective as January 1, 2018.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

MoneyTrac Technology, Inc. Prepares for Growth with Changes in Management, Including the Appointment of Vanessa Luna as CEO

Global Payout, Inc. CEO, James H., Reflects on the Highlights, and Achievements of 2017

Global Payout, Inc. Developing New Subsidiary to Focus on Blockchain Technology Solutions for the Trillion Dollar Logistics Industry

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA). Today, Marijuana Company of America Inc. closed trading at $0.061, off by 5.59%, on 39,526,597 volume with 2,373 trades. The stock’s average daily volume over the past 60 days is 11,615,286 and its 52-week low/high is $0.0181/$0.114.

Marijuana Company of America Inc. (MCOA) is pleased to announce its 2017 year-end review to its valued shareholders and interested parties. Donald Steinberg, CEO of MCOA, said: “I am the founder of multiple startups, including Medical Marijuana Inc. (OTC:MJNA), which has a market cap of over 300 million dollars. I am aware of the challenges and opportunities these endeavors present, and the need for a strong foundation to build upon.

Marijuana Company of America Inc. (MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA's CEO, founded the first marijuana company ever to trade on a US stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can also be used to produce products that are carbon neutral or even carbon negative, like the longest, strongest natural fiber on earth, building materials that are mold, pest and fire proof, super foods and so much more for additional business opportunities. No part of the plant is left unused and the Company's overall stategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented exponential growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015's $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal and cannabis and industrial hemp sectors. The Company's business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA's strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product "hempSMART Brain," is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience. Disclaimer

Marijuana Company of America Inc. Blog

Marijuana Company of America Inc. News:

Marijuana Company of America’s Overview of 2017 Highlights

Marijuana Company of America Launches New hempSMART™ Pain Product

Marijuana Company of America Partners With HoneyB Healthy Living to Launch the BeniHemp Brand

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.0056, off by 34.12%, on 28,002,992 volume with 278 trades. The stock’s average daily volume over the past 60 days is 9,830,008 and its 52-week low/high is $0.0027/$0.1499.

Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that it has launched CBD.co, a marketplace of CBD products featuring suppliers and products. CBD.co is anticipated to become the definitive destination on the web for all things hemp and CBD, according to Patrick Stiles, Chief Executive Office of Grey Cloak Tech, Inc.

Grey Cloak Tech, Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, aims to expand into the rapidly growing cannabinoid (CBD) market through the pending acquisition of Eqova Life Sciences, which focuses on providing a full spectrum line of clinical-grade hemp oil (CBD) products to the medical practitioner market. Eqova Life Sciences, based in Denver, Colorado, develops its own high quality, branded product line of hemp oil health products, with the offer of producing private labels to qualified partners.

Eqova Life Sciences recently exhibited the company's CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company's formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.

According to The Hemp Business Journal, the CBD products marketplace is projected to grow 700 percent by 2020 with annual sales reaching $2.1 billion. The purchase of Eqova Life Sciences would be a natural fit for the company, which has been looking for a way to build shareholder value by adding acquisitions from the rapidly growing CBD sector. Grey Cloak Tech believes medical practitioners seeking high-quality CBD products represent a vastly underserved market. To date, no other hemp oil company has exclusively focused on providing clinical-grade, full-spectrum hemp oil products to this important segment of the medical community.

Grey Cloak Tech also develops advanced software to overcome costly digital threats, most commonly known as online fraud. Grey Cloak Tech leads the industry with continuous development of the most comprehensive and effective weapons against online security threats. The company's proprietary digital advertising fraud detection software, Fraudlytic, provides a cloud-based, secure platform that monitors Internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and make purchases. Disclaimer

Grey Cloak Tech, Inc. Blog

Grey Cloak Tech, Inc. News:

Grey Cloak Announces the Launch of CBD.co — “The Cannabinoid Marketplace”

Grey Cloak Tech Announces Hiring of Stephen Goldberg as New Chief Marketing Officer for CBD.co

Grey Cloak Tech, Inc. Announces Purchase of CBD.co Domain and Plans to Build a CBD Marketplace

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Profitable Trader Authority
(CHIT) +250.00%

2.

MarketBeat
(XSNX) +146.15%

3.

PennyStockLocks
(HPMM) +135.59%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251